Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Viemed Healthcare (VMD) Invested Capital (2018 - 2026)

Viemed Healthcare filings provide 8 years of Invested Capital readings, the most recent being $144.6 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 9.72% to $144.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $144.6 million, a 9.72% increase, with the full-year FY2025 number at $144.6 million, up 9.72% from a year prior.
  • Invested Capital hit $144.6 million in Q4 2025 for Viemed Healthcare, up from $137.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $144.6 million in Q4 2025 to a low of $90.6 million in Q1 2021.
  • Median Invested Capital over the past 5 years was $106.8 million (2023), compared with a mean of $113.1 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 56.89% in 2021 and later dropped 3.49% in 2022.
  • Viemed Healthcare's Invested Capital stood at $100.6 million in 2021, then dropped by 3.49% to $97.1 million in 2022, then rose by 18.41% to $115.0 million in 2023, then grew by 14.64% to $131.8 million in 2024, then increased by 9.72% to $144.6 million in 2025.
  • The last three reported values for Invested Capital were $144.6 million (Q4 2025), $137.0 million (Q3 2025), and $142.4 million (Q2 2025) per Business Quant data.